Delivery Order SPE2DB22D2206-SPE2DB25FJE43
Award Date 7/31/25
Potential Completion Date 8/21/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp for FOTIVDA 1.34 mg capsule supply (21-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract is not set-aside and represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FOTIVDA 0.89 MG CAPSULE 21S. The contract has a firm fixed price of $16,135.20 and a period of performance extending to July 3, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FOTIVDA 1.34 MG CAPSULE 21S, a pharmaceutical product, with a ceiling value of $15,953.54 and a completion date of July 2, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
- The Defense Logistics Agency awarded a delivery order valued at thirty thousand eight hundred forty-one dollars and sixteen cents ($30,841.16) to Amerisourcebergen Drug Corporation for FOTIVDA 1.34 MG capsules. Under this firm fixed price contract, Amerisourcebergen will deliver twenty-one (21) capsules of the pharmaceutical product to a location in Conshohocken, Pennsylvania by August 24, 2023 in support of DLA programs. No major subcontractors or set aside designations were identified. This...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $31,192.36, is for the supply of the pharmaceutical product FOTIVDA 0.89 MG CAPSULE 21S. As a prime contractor, Amerisourcebergen Drug Corp has provided a range of pharmaceutical and medical products to support DLA Troop Support Medical programs and facilities. The contract has a completion date of January...
- This is a $15,953.54 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FOTIVDA 1.34 MG CAPSULE 21S, with a performance period ending on July 28, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,777.70 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Enhertu 100 mg vials, a specialized pharmaceutical product. The contract is firm fixed price with an ultimate completion date of August 11, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award is a non-set-aside competitive procurement, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- AmerisourceBergen Drug Corp received a delivery order valued at $21,806.25 from the Defense Logistics Agency for 40 mg vials of TIVDAK, awarded on July 28, 2025, with an ultimate completion date of August 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement procedures. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $13,083.75 to AmerisourceBergen Drug Corp for the supply of Tivdak 40 mg vials, a chemotherapy medication. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- AmerisourceBergen Drug Corp was awarded a $2,462.36 delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Terlivaz 0.85 mg vials, with a completion date of August 20, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a...